Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Jun;48(6):849–852. doi: 10.1136/gut.48.6.849

Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine

F Durand 1, J Bernuau 1, E Giostra 1, G Mentha 1, D Shouval 1, C Degott 1, J Benhamou 1, D Valla 1
PMCID: PMC1728316  PMID: 11358907

Abstract

BACKGROUND—Wilson's disease, heralded by severe hepatic insufficiency, is a rare disorder for which emergency liver transplantation is considered to be the only effective therapy.
AIMS—To report the features of Wilson's disease with severe hepatic insufficiency in a series of 17 patients and, during the second period of the study, to assess the efficacy of a policy consisting of early administration of D-penicillamine.
PATIENTS—Seventeen consecutive patients with Wilson's disease were studied. During the first period of the study (up to 1979), none of the patients received D-penicillamine. During the second period (after 1979), all patients without encephalopathy at admission received D-penicillamine.
RESULTS—The four patients observed during the first period who did not have encephalopathy at admission and did not receive D-penicillamine progressed to encephalopathy and died. Among the 13 consecutive patients observed during the second period, two patients with encephalopathy at admission did not receive D-penicillamine and were transplanted. The 11 remaining patients all received D-penicillamine. Ten of these patients survived without the need for transplantation and returned to compensated liver disease without liver insufficiency. In one patient, liver insufficiency progressed and transplantation had to be performed.
CONCLUSIONS—In most patients with Wilson's disease heralded by severe hepatic insufficiency and without encephalopathy at admission, early administration of D-penicillamine was associated with survival without transplantation. These results suggest the importance of early diagnosis of this form of Wilson's disease before the onset of encephalopathy, and favour early administration of D-penicillamine which could avoid the need for transplantation in most cases.


Keywords: Wilson's disease; acute liver failure; liver transplantation; hepatic encephalopathy

Full Text

The Full Text of this article is available as a PDF (107.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellary S., Hassanein T., Van Thiel D. H. Liver transplantation for Wilson's disease. J Hepatol. 1995 Oct;23(4):373–381. doi: 10.1016/0168-8278(95)80194-4. [DOI] [PubMed] [Google Scholar]
  2. Bernuau J., Rueff B., Benhamou J. P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986 May;6(2):97–106. doi: 10.1055/s-2008-1040593. [DOI] [PubMed] [Google Scholar]
  3. Brewer G. J., Johnson V., Dick R. D., Kluin K. J., Fink J. K., Brunberg J. A. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 1996 Oct;53(10):1017–1025. doi: 10.1001/archneur.1996.00550100103019. [DOI] [PubMed] [Google Scholar]
  4. Brunel E., Thomas R., Brissot P. Hémolyse aiguë et insuffisance rénale révélant une maladie de Wilson (MW). Diagnostic et indications thérapeutiques. Nouv Presse Med. 1981 May 16;10(22):1841–1842. [PubMed] [Google Scholar]
  5. De Bont B., Moulin D., Stein F., Van Hoof F., Lauwerys R. Peritoneal dialysis with D-penicillamine in Wilson disease. J Pediatr. 1985 Oct;107(4):545–547. doi: 10.1016/s0022-3476(85)80014-7. [DOI] [PubMed] [Google Scholar]
  6. Hartleb M., Zahorska-Markiewicz B., Ciesielski A. Wilson's disease presenting in sisters as fulminant hepatitis with hemolytic episodes. Am J Gastroenterol. 1987 Jun;82(6):549–551. [PubMed] [Google Scholar]
  7. Heilmaier H. E., Jiang J. L., Greim H., Schramel P., Summer K. H. D-penicillamine induces rat hepatic metallothionein. Toxicology. 1986 Dec 1;42(1):23–31. doi: 10.1016/0300-483x(86)90089-2. [DOI] [PubMed] [Google Scholar]
  8. Klein D., Lichtmannegger J., Heinzmann U., Summer K. H. Dissolution of copper-rich granules in hepatic lysosomes by D-penicillamine prevents the development of fulminant hepatitis in Long-Evans cinnamon rats. J Hepatol. 2000 Feb;32(2):193–201. doi: 10.1016/s0168-8278(00)80063-x. [DOI] [PubMed] [Google Scholar]
  9. McCullough A. J., Fleming C. R., Thistle J. L., Baldus W. P., Ludwig J., McCall J. T., Dickson E. R. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology. 1983 Jan;84(1):161–167. [PubMed] [Google Scholar]
  10. Nazer H., Larcher V. F., Ede R. J., Mowat A. P., Williams R. Wilson's disease: a diagnostic dilemma. Br Med J (Clin Res Ed) 1983 Jul 30;287(6388):313–314. doi: 10.1136/bmj.287.6388.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rakela J., Kurtz S. B., McCarthy J. T., Ludwig J., Ascher N. L., Bloomer J. R., Claus P. L. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 1986 Jun;90(6):2004–2007. doi: 10.1016/0016-5085(86)90274-x. [DOI] [PubMed] [Google Scholar]
  12. Roche-Sicot J., Benhamou J. P. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med. 1977 Mar;86(3):301–303. doi: 10.7326/0003-4819-86-3-301. [DOI] [PubMed] [Google Scholar]
  13. STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
  14. Scheinberg I. H., Sternlieb I., Schilsky M., Stockert R. J. Penicillamine may detoxify copper in Wilson's disease. Lancet. 1987 Jul 11;2(8550):95–95. doi: 10.1016/s0140-6736(87)92753-x. [DOI] [PubMed] [Google Scholar]
  15. Stampfl D. A., Muñoz S. J., Moritz M. J., Rubin R., Armenti V. T., Jarrell B. E., Maddrey W. C. Heterotopic liver transplantation for fulminant Wilson's disease. Gastroenterology. 1990 Dec;99(6):1834–1836. doi: 10.1016/0016-5085(90)90497-o. [DOI] [PubMed] [Google Scholar]
  16. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 1990 Nov;12(5):1234–1239. doi: 10.1002/hep.1840120526. [DOI] [PubMed] [Google Scholar]
  17. Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology. 1984 Jan-Feb;4(1 Suppl):15S–17S. doi: 10.1002/hep.1840040706. [DOI] [PubMed] [Google Scholar]
  18. Walia B. N., Singh S., Marwaha R. K., Bhusnurmath S. R., Dilawari J. B. Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children. J Gastroenterol Hepatol. 1992 Jul-Aug;7(4):370–373. doi: 10.1111/j.1440-1746.1992.tb01000.x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES